Effects of Rituximab Dose on Hepatitis B Reactivation in Patients With Resolved Infection Undergoing Immunologic Incompatible Kidney Transplantation

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-34111-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Rituximab and Hypogammaglobulinemia in the Setting of ABO-incompatible Kidney Transplantation

Journal of Nephropathology
Nephrology
2017English

Role of Anti-HBS Titer to Prevent Reactivation of Hepatitis B After Kidney Transplant in a Patient With Resolved Hepatitis B Infection: A Case Report and Review of Literature

Gastroenterology & Hepatology Research
2017English

Hepatitis B Reactivation in Occult Viral Carriers Undergoing Hematopoietic Stem Cell Transplantation: A Prospective Study

Hepatology
MedicineHepatology
2017English

ABO-incompatible Kidney Transplantation

2011English

ABO-Incompatible Kidney Transplantation

2016English

Low Dose of Mycophenolate Mofetil Is Enough in Desensitized Kidney Transplantation Using Rituximab

BMC Nephrology
Nephrology
2015English

Occult Hepatitis B Reactivation

Viral Hepatit Dergisi
2015English

Reactivation of Occult Hepatitis B Virus Infection Under Treatment With Abatacept: A Case Report

BMC pharmacology & toxicology
MedicinePharmacology
2016English

Mouse Models of Hepatitis B Virus Infection Comprising Host-Virus Immunologic Interactions

Pathogens
ImmunologyMolecular BiologyAllergyMicrobiologyMicrobiology Infectious Diseases
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy